vs

Side-by-side financial comparison of DoubleVerify Holdings, Inc. (DV) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

DoubleVerify Holdings, Inc. is the larger business by last-quarter revenue ($205.6M vs $186.7M, roughly 1.1× NEOGENOMICS INC). DoubleVerify Holdings, Inc. runs the higher net margin — 14.3% vs -57.9%, a 72.1% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 7.9%). Over the past eight quarters, DoubleVerify Holdings, Inc.'s revenue compounded faster (20.8% CAGR vs 6.5%).

Double Vision is a Malaysian production studio. Established in 1985, it has production hubs in Malaysia and Indonesia. Double Vision produces over 1,400 hours of television programming per year in various languages and genres for the regional market. It also houses international entertainment TV network, Channel [V], in its studios.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

DV vs NEO — Head-to-Head

Bigger by revenue
DV
DV
1.1× larger
DV
$205.6M
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+3.2% gap
NEO
11.1%
7.9%
DV
Higher net margin
DV
DV
72.1% more per $
DV
14.3%
-57.9%
NEO
Faster 2-yr revenue CAGR
DV
DV
Annualised
DV
20.8%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DV
DV
NEO
NEO
Revenue
$205.6M
$186.7M
Net Profit
$29.3M
$-108.0M
Gross Margin
82.5%
43.3%
Operating Margin
18.4%
46.9%
Net Margin
14.3%
-57.9%
Revenue YoY
7.9%
11.1%
Net Profit YoY
25.3%
42.0%
EPS (diluted)
$0.18
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DV
DV
NEO
NEO
Q1 26
$186.7M
Q4 25
$205.6M
$190.2M
Q3 25
$188.6M
$187.8M
Q2 25
$189.0M
$181.3M
Q1 25
$165.1M
$168.0M
Q4 24
$190.6M
$172.0M
Q3 24
$169.6M
$167.8M
Q2 24
$155.9M
$164.5M
Net Profit
DV
DV
NEO
NEO
Q1 26
$-108.0M
Q4 25
$29.3M
Q3 25
$10.2M
$-27.1M
Q2 25
$8.8M
$-45.1M
Q1 25
$2.4M
$-25.9M
Q4 24
$23.4M
Q3 24
$18.2M
$-17.7M
Q2 24
$7.5M
$-18.6M
Gross Margin
DV
DV
NEO
NEO
Q1 26
43.3%
Q4 25
82.5%
43.8%
Q3 25
82.3%
42.8%
Q2 25
82.5%
42.6%
Q1 25
81.2%
43.6%
Q4 24
82.0%
44.9%
Q3 24
82.6%
44.6%
Q2 24
83.3%
44.1%
Operating Margin
DV
DV
NEO
NEO
Q1 26
46.9%
Q4 25
18.4%
-7.1%
Q3 25
11.2%
-14.4%
Q2 25
7.2%
-26.3%
Q1 25
4.1%
-16.6%
Q4 24
20.3%
-10.7%
Q3 24
15.2%
-12.6%
Q2 24
7.1%
-13.3%
Net Margin
DV
DV
NEO
NEO
Q1 26
-57.9%
Q4 25
14.3%
Q3 25
5.4%
-14.4%
Q2 25
4.6%
-24.9%
Q1 25
1.4%
-15.4%
Q4 24
12.3%
Q3 24
10.7%
-10.5%
Q2 24
4.8%
-11.3%
EPS (diluted)
DV
DV
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.18
Q3 25
$0.06
Q2 25
$0.05
Q1 25
$0.01
Q4 24
$0.14
Q3 24
$0.10
Q2 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DV
DV
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$259.0M
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$828.8M
Total Assets
$1.4B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DV
DV
NEO
NEO
Q1 26
$146.1M
Q4 25
$259.0M
$159.6M
Q3 25
$200.7M
$164.1M
Q2 25
$216.8M
$154.7M
Q1 25
$174.3M
$346.2M
Q4 24
$310.6M
$367.0M
Q3 24
$362.6M
$362.0M
Q2 24
$338.8M
$355.1M
Total Debt
DV
DV
NEO
NEO
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
DV
DV
NEO
NEO
Q1 26
$828.8M
Q4 25
$1.1B
$836.6M
Q3 25
$1.1B
$838.3M
Q2 25
$1.1B
$854.0M
Q1 25
$1.0B
$888.3M
Q4 24
$1.1B
$902.3M
Q3 24
$1.1B
$908.2M
Q2 24
$1.1B
$915.9M
Total Assets
DV
DV
NEO
NEO
Q1 26
$1.3B
Q4 25
$1.4B
$1.4B
Q3 25
$1.3B
$1.4B
Q2 25
$1.3B
$1.4B
Q1 25
$1.2B
$1.6B
Q4 24
$1.3B
$1.6B
Q3 24
$1.3B
$1.6B
Q2 24
$1.3B
$1.6B
Debt / Equity
DV
DV
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DV
DV
NEO
NEO
Operating Cash FlowLast quarter
$72.7M
$-8.1M
Free Cash FlowOCF − Capex
$62.1M
FCF MarginFCF / Revenue
30.2%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
2.48×
TTM Free Cash FlowTrailing 4 quarters
$172.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DV
DV
NEO
NEO
Q1 26
$-8.1M
Q4 25
$72.7M
$1.3M
Q3 25
$51.2M
$8.9M
Q2 25
$49.6M
$20.3M
Q1 25
$37.7M
$-25.3M
Q4 24
$37.4M
$9.8M
Q3 24
$54.6M
$9.2M
Q2 24
$35.9M
$13.9M
Free Cash Flow
DV
DV
NEO
NEO
Q1 26
Q4 25
$62.1M
$-6.5M
Q3 25
$39.0M
$570.0K
Q2 25
$40.1M
$14.0M
Q1 25
$31.4M
$-29.8M
Q4 24
$30.0M
$-1.8M
Q3 24
$48.4M
$-1.6M
Q2 24
$28.7M
$814.0K
FCF Margin
DV
DV
NEO
NEO
Q1 26
Q4 25
30.2%
-3.4%
Q3 25
20.7%
0.3%
Q2 25
21.2%
7.7%
Q1 25
19.0%
-17.8%
Q4 24
15.8%
-1.0%
Q3 24
28.5%
-0.9%
Q2 24
18.4%
0.5%
Capex Intensity
DV
DV
NEO
NEO
Q1 26
Q4 25
5.1%
4.1%
Q3 25
6.4%
4.4%
Q2 25
5.0%
3.5%
Q1 25
3.8%
2.7%
Q4 24
3.9%
6.7%
Q3 24
3.7%
6.4%
Q2 24
4.6%
8.0%
Cash Conversion
DV
DV
NEO
NEO
Q1 26
Q4 25
2.48×
Q3 25
5.02×
Q2 25
5.66×
Q1 25
15.95×
Q4 24
1.60×
Q3 24
3.00×
Q2 24
4.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DV
DV

Activation$116.5M57%
Measurement$69.6M34%
Supply Side$19.5M9%

NEO
NEO

Segment breakdown not available.

Related Comparisons